Search tips
Search criteria 


Logo of acgcaserepsLink to Publisher's site
ACG Case Rep J. 2017; 4: e46.
Published online 2017 March 29. doi:  10.14309/crj.2017.46
PMCID: PMC5371719

Chronic Granulomatous Disease Mimicking Colonic Crohn’s Disease Successfully Treated with Infliximab

Armando Peixoto, MD,corresponding author1,2 Rosa Coelho, MD,1,2 Tiago Maia, MD,3 António Sarmento, PhD,4 Fernando Magro, PhD,1,2,5,6 and Guilherme Macedo, PhD1,2


Chronic granulomatous disease (CGD) is a genetically induced disease caused by mutations in one of the components of the NADPH-oxidase in phagocytes, characterized by life-threatening bacterial and fungal infections and granuloma formation. Treatment includes prevention of infectious complications and immunomodulation. However, a standard strategy is not yet defined. The authors report an X-linked CGD female carrier who presented during adulthood with diarrhea and colorectal ulcers, with high impairment of quality of life. Induction with infliximab 5 mg/kg (weeks 0, 2, and 6) with infectious prophylaxis was initiated. She continued infliximab 5 mg/kg every 8 weeks with complete symptomatic response at 15 months.

Articles from ACG Case Reports Journal are provided here courtesy of American College of Gastroenterology